FDA is offering grants for Critical Path Public-Private Partnerships to foster medical product innovation and accelerate development. These grants aim to facilitate collaborations through cooperative agreements, promoting research, education, and outreach for enhancing medical product safety and translational therapeutics. Applications are welcome until July 29, 2019.
Opportunity ID: 316483
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-19-027 |
| Funding Opportunity Title: | Renewal Application: Critical Path Public Private Partnerships (U18) Clinical Trials Optional |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Agriculture Consumer Protection Food and Nutrition |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.103 — Food and Drug Administration Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 29, 2019 |
| Last Updated Date: | May 29, 2019 |
| Original Closing Date for Applications: | Jul 29, 2019 |
| Current Closing Date for Applications: | Jul 29, 2019 |
| Archive Date: | Aug 28, 2019 |
| Estimated Total Program Funding: | $20,000,000 |
| Award Ceiling: | $100,000,000 |
| Award Floor: | $10,000,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible OrganizationsThe following organization is eligible to apply:Critical Path Institute |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: | As part of its Critical Path Initiative, FDA recognizes the need for collaborations established under the terms and conditions of a cooperative agreement to facilitate Critical Path Public-Private Partnerships / Consortia activities. This includes developing innovative, collaborative projects in research, education, and outreach for fostering medical product innovation, enabling the acceleration of medical product development, manufacturing, and translational therapeutics, and enhancing medical product safety. |
| Link to Additional Information: | Full Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Shashi Malhotra
Grants Management Specialist Phone 2404027592 Email:shashi.malhotra@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Shashi Malhotra Grants Management Specialist Phone 2404027592 Email: shashi.malhotra@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | RFA-FD-19-027 | FORM E | PKG00251444 | May 29, 2019 | Jul 29, 2019 | View |
Package 1
Mandatory forms
316483 RR_SF424_2_0-2.0.pdf
316483 PHS398_CoverPageSupplement_4_0-4.0.pdf
316483 RR_OtherProjectInfo_1_4-1.4.pdf
316483 PerformanceSite_2_0-2.0.pdf
316483 RR_KeyPersonExpanded_2_0-2.0.pdf
316483 RR_Budget_1_4-1.4.pdf
316483 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
316483 RR_SubawardBudget30_1_4-1.4.pdf
316483 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
